How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

34,964 results for

Plaque

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. [Ixekizumab (plaque psoriasis) - addendum to Commission A17-07]

[Ixekizumab (plaque psoriasis) - addendum to Commission A17-07] Ixekizumab (Plaque Psoriasis): Addendum zum Auftrag A17-07; Auftrag A17-30 [Ixekizumab (plaque psoriasis) - addendum to Commission A17-07] Ixekizumab (Plaque Psoriasis): Addendum zum Auftrag A17-07; Auftrag A17-30 [Ixekizumab (plaque psoriasis) - addendum to Commission A17-07] Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen Record Status This is a bibliographic record of a published health technology assessment (...) from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen. Ixekizumab (Plaque Psoriasis): Addendum zum Auftrag A17-07; Auftrag A17-30. [Ixekizumab (plaque psoriasis) - addendum to Commission A17-07] Cologne: Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). IQWiG-Berichte 528. 2017 Final publication URL Indexing Status Subject indexing assigned

2017 Health Technology Assessment (HTA) Database.

22. [Secukinumab (plaque psoriasis) - benefit assessment according to õ35a Social Code Book V (new scientific findings)]

[Secukinumab (plaque psoriasis) - benefit assessment according to õ35a Social Code Book V (new scientific findings)] Secukinumab (plaque-psoriasis): nutzenbewertung gemäß § 35a SGB V (neue wissenschaftliche erkenntnisse); dossierbewertung [Secukinumab (plaque psoriasis) - benefit assessment according to §35a Social Code Book V (new scientific findings)] Secukinumab (plaque-psoriasis): nutzenbewertung gemäß § 35a SGB V (neue wissenschaftliche erkenntnisse); dossierbewertung [Secukinumab (plaque (...) psoriasis) - benefit assessment according to §35a Social Code Book V (new scientific findings)] Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen. Secukinumab (plaque-psoriasis): nutzenbewertung gemäß § 35a SGB V (neue

2017 Health Technology Assessment (HTA) Database.

23. [Ixekizumab (plaque psoriasis) - benefit assessment according to õ35a Social Code Book V]

[Ixekizumab (plaque psoriasis) - benefit assessment according to õ35a Social Code Book V] Ixekizumab (Plaque Psoriasis): nutzenbewertung gemäß § 35a SGB V; dossierbewertung; auftrag A17-07 [Ixekizumab (plaque psoriasis) - benefit assessment according to §35a Social Code Book V] Ixekizumab (Plaque Psoriasis): nutzenbewertung gemäß § 35a SGB V; dossierbewertung; auftrag A17-07 [Ixekizumab (plaque psoriasis) - benefit assessment according to §35a Social Code Book V] Institut für Qualität und (...) Wirtschaftlichkeit im Gesundheitswesen Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen. Ixekizumab (Plaque Psoriasis): nutzenbewertung gemäß § 35a SGB V; dossierbewertung; auftrag A17-07. [Ixekizumab (plaque psoriasis) - benefit assessment according to §35a Social Code Book V] Cologne

2017 Health Technology Assessment (HTA) Database.

24. Anti-plaque agents: do they help reduce plaque levels?

Anti-plaque agents: do they help reduce plaque levels? Anti-plaque agents: do they help reduce plaque levels? - National Elf Service Search National Elf Service Search National Elf Service » » » » Anti-plaque agents: do they help reduce plaque levels? Oct 18 2016 Posted by Gingivitis and periodontal disease are very common. Prevention is dependent on good control of the supragingival biofilm. Reviews have demonstrated the effectiveness of some anti-plaque agents but comparisons between products (...) is more limited. The aim of this review and network meta-analysis (NMA) was to compare the efficacy of different anti-plaque chemical agents, in 6-month, home-use, in terms of plaque index (PlI) changes. Methods A search was conducted in PubMed central database. Randomised controlled trials (RCTs) with at least 6 month follow up evaluating the use of test products used in mouthrinses, toothpastes or gels as adjuncts to mechanical oral hygiene (including toothbrushing) were considered. Two reviewers

2016 The Dental Elf

25. In Systemically Healthy Patients with Gingivitis, Mechanical Plaque Control with The Adjunctive Use of Essential Oils Containing Mouthrinses (MMEO) Reduced Plaque and Gingivitis Greater Than Mechanical Methods (MM) Alone

In Systemically Healthy Patients with Gingivitis, Mechanical Plaque Control with The Adjunctive Use of Essential Oils Containing Mouthrinses (MMEO) Reduced Plaque and Gingivitis Greater Than Mechanical Methods (MM) Alone UTCAT2944, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title In Systemically Healthy Patients with Gingivitis, Mechanical Plaque Control with The Adjunctive Use of Essential Oils Containing Mouthrinses (...) (MMEO) Reduced Plaque and Gingivitis Greater Than Mechanical Methods (MM) Alone Clinical Question In healthy patients with gingivitis, does the adjunctive use of essential oils containing mouthrinses with mechanical methods reduce plaque and gingivitis more than mechanical methods alone? Clinical Bottom Line The use of essential oils mouthrinse as an adjunctive to mechanical plaque removal provided statistically significantly greater odds of having healthy gingiva and in reducing plaque

2015 UTHSCSA Dental School CAT Library

26. Targeted Immunomodulators for the Treatment of Moderate-to-Severe Plaque Psoriasis: Effectiveness and Value

Targeted Immunomodulators for the Treatment of Moderate-to-Severe Plaque Psoriasis: Effectiveness and Value ©Institute for Clinical and Economic Review, 2016 Targeted Immunomodulators for the Treatment of Moderate-to-Severe Plaque Psoriasis: Effectiveness and Value Final Evidence Report December 2, 2016 Prepared for ©Institute for Clinical and Economic Review, 2016 Page ii Final Evidence Report -Targeted Immunomodulators for the Treatment of Moderate-Severe Plaque Psoriasis Return to Table (...) Institute for Clinical and Economic Review, 2016 Page iii Final Evidence Report -Targeted Immunomodulators for the Treatment of Moderate-Severe Plaque Psoriasis Return to Table of Contents Disclosure Statement: Dr. Linder owns stock in Amgen, Biogen, and Eli Lily, has contingent value rights in Sanofi Genzyme (related to alemtuzumab for multiple sclerosis); in the past 3 years, Dr. Linder has received grant support from Astellas Pharma on an unrelated topic (overactive bladder) and Clintrex, which

2017 California Technology Assessment Forum

27. Air Polishing with Glycine Powder for Plaque and Stain Removal is Safer on Hard and Soft Tissues than Air Polishing with Sodium Bicarbonate Powder

Air Polishing with Glycine Powder for Plaque and Stain Removal is Safer on Hard and Soft Tissues than Air Polishing with Sodium Bicarbonate Powder UTCAT3270, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title Air Polishing with Glycine Powder for Plaque and Stain Removal is Safer on Hard and Soft Tissues than Air Polishing with Sodium Bicarbonate Powder Clinical Question Is air polishing with glycine powder for plaque (...) and stain removal safer on hard and soft periodontal tissues compared to air polishing with sodium bicarbonate powder? Clinical Bottom Line Air polishing with glycine powder for plaque and stain removal is safer on hard and soft tissues than air polishing with sodium bicarbonate. Systematic review analysis showed four studies reporting data on the outcome with respect to the state of gingival erosion and gingival trauma. Surface modifications on cementum and dentine were addressed in 13 studies

2017 UTHSCSA Dental School CAT Library

28. Dental water jets have not been demonstrated to be more effective than floss at removing interproximal plaque.

Dental water jets have not been demonstrated to be more effective than floss at removing interproximal plaque. UTCAT3279, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title Dental water jets have not been demonstrated to be more effective than floss at removing interproximal plaque. Clinical Question Are dental water jets more effective than floss in the removal of interproximal plaque? Clinical Bottom Line (...) There is insufficient evidence at this time to indicate that either the dental water jet or dental floss are more effective at removing interproximal plaque. Best Evidence (you may view more info by clicking on the PubMed ID link) PubMed ID Author / Year Patient Group Study type (level of evidence) #1) Salzer/2015 6 systematic reviews/3534 patients Meta-Analysis Key results Of the two systematic reviews regarding the use of dental floss, one found no statistically significant benefit of flossing in addition

2017 UTHSCSA Dental School CAT Library

29. Turmeric in a Mouth Rinse or in Gel Form Can Be Used to Reduce Plaque Accumulation and to Prevent and Treat Gingivitis as Effectively as a Chlorhexidine Mouth Rinse

Turmeric in a Mouth Rinse or in Gel Form Can Be Used to Reduce Plaque Accumulation and to Prevent and Treat Gingivitis as Effectively as a Chlorhexidine Mouth Rinse UTCAT3155, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title Turmeric in a Mouth Rinse or in Gel Form Can Be Used to Reduce Plaque Accumulation and to Prevent and Treat Gingivitis as Effectively as a Chlorhexidine Mouth Rinse Clinical Question Compared (...) to mouth rinses or gels containing chlorhexidine, what is the impact of turmeric mouth rinses or gels on plaque level and gingival inflammation? Clinical Bottom Line A mouth rinse or gel containing turmeric can be used to reduce plaque accumulation and to prevent and treat gingivitis. Turmeric mouth rinse and gels may be just as effective as chlorhexidine without the side effects of chlorhexidine. Four out of the five studies in a systematic review show that turmeric had plaque- and gingivitis-reducing

2017 UTHSCSA Dental School CAT Library

30. Chlorhexidine Mouth Rinse Twice a Day Is at Least as Effective as Dental Floss in Reducing Plaque Buildup

Chlorhexidine Mouth Rinse Twice a Day Is at Least as Effective as Dental Floss in Reducing Plaque Buildup UTCAT3138, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title Chlorhexidine Mouth Rinse Twice a Day Is at Least as Effective as Dental Floss in Reducing Plaque Buildup Clinical Question In adult patients, does regular tooth brushing with adjunctive dental floss more effectively reduce plaque index as compared (...) to regular tooth brushing with adjunctive chlorhexidine mouth rinse? Clinical Bottom Line In adult patients, chlorhexidine mouth rinse is at least as effective as dental floss as an adjunct to regular tooth brushing in reducing plaque index. This is supported by two randomized control trials conducted in India, which showed that use of chlorhexidine mouth rinse resulted in clinically significant reductions in plaque indices as compared to dental floss. Prescription of chlorhexidine mouth rinse is within

2017 UTHSCSA Dental School CAT Library

31. Adalimumab (Humira) and plaque psoriasis in children: no better than other immunosuppressants

Adalimumab (Humira) and plaque psoriasis in children: no better than other immunosuppressants Prescrire IN ENGLISH - Spotlight ''In the July issue of Prescrire International - Adalimumab (Humira°) and plaque psoriasis in children: no better than other immunosuppressants'', 1 July 2016 {1} {1} {1} | | > > > In the July issue of Prescrire International - Adalimumab (Humira°) and plaque psoriasis in children: no better than other immunosuppressants Spotlight Every month, the subjects (...) in Prescrire’s Spotlight. 100 most recent :  |   |   |   |   |   |   |   |   |  Spotlight In the July issue of Prescrire International - Adalimumab (Humira°) and plaque psoriasis in children: no better than other immunosuppressants FREE DOWNLOAD In a trial in 114 children, the efficacy of adalimumab was not notably different from that of methotrexate, and its adverse effects profile did not appear to be more favourable. Full text

2016 Prescrire

32. Quantitative coronary plaque analysis predicts high-risk plaque morphology on coronary computed tomography angiography: results from the ROMICAT II trial. (PubMed)

Quantitative coronary plaque analysis predicts high-risk plaque morphology on coronary computed tomography angiography: results from the ROMICAT II trial. Semi-automated software can provide quantitative assessment of atherosclerotic plaques on coronary CT angiography (CTA). The relationship between established qualitative high-risk plaque features and quantitative plaque measurements has not been studied. We analyzed the association between quantitative plaque measurements and qualitative high (...) -risk plaque features on coronary CTA. We included 260 patients with plaque who underwent coronary CTA in the Rule Out Myocardial Infarction/Ischemia Using Computer Assisted Tomography (ROMICAT) II trial. Quantitative plaque assessment and qualitative plaque characterization were performed on a per coronary segment basis. Quantitative coronary plaque measurements included plaque volume, plaque burden, remodeling index, and diameter stenosis. In qualitative analysis, high-risk plaque was present

Full Text available with Trip Pro

2018 The international journal of cardiovascular imaging

33. An Evaluation of Plaque and Gingivitis Reduction Following Home Use of Sonicare FlexCare Platinum with Premium Plaque Control Brush Head and a Manual Toothbrush. (PubMed)

An Evaluation of Plaque and Gingivitis Reduction Following Home Use of Sonicare FlexCare Platinum with Premium Plaque Control Brush Head and a Manual Toothbrush. To assess the effect of the Philips Sonicare FlexCare Platinum with Premium plaque control brush head on gingival inflammation, bleeding, and supragingival plaque reduction following a six-week period of home use compared to a manual toothbrush.This was a randomized, single-blind, parallel-design clinical trial. Subjects included (...) in the study were routine manual toothbrush users who were generally healthy non-smokers, aged 18-65 years, with mild to moderate gingivitis. Subjects with advanced periodontal disease, excessive gingival recession, and heavy deposits of calculus or rampant decay were excluded from the study. Eligible participants were dispensed either Philips Sonicare FlexCare Platinum with Premium plaque control brush head (PC), or an ADA Reference manual toothbrush (MTB) for twice-daily home oral hygiene procedures

2018 The Journal of clinical dentistry

34. Impact of combined lipid lowering and blood pressure control on coronary plaque: myocardial ischemia treated by percutaneous coronary intervention and plaque regression by lipid lowering and blood pressure controlling assessed by intravascular ultrasonogr (PubMed)

Impact of combined lipid lowering and blood pressure control on coronary plaque: myocardial ischemia treated by percutaneous coronary intervention and plaque regression by lipid lowering and blood pressure controlling assessed by intravascular ultrasonogr The aim of the study was to elucidate the aggressive reduction of both low-density lipoprotein cholesterol (LDL-C) and blood pressure (BP) reduced coronary atherosclerotic plaque volume compared with a standard treatment of LDL-C and BP (...) of 100 mg/dL and 140/90 mmHg vs. 70 mg/dL and 120/70 mmHg, respectively. The primary endpoint was the percent change in coronary plaque volume. Both standard and aggressive strategies succeeded to achieve target levels of LDL-C and BP; 74.9 ± 14.7 vs. 63.7 ± 11.9 mg/dL (NS) and 124.1 ± 9.4/75.8 ± 7.7 vs. 113.6 ± 9.6/65.8 ± 9.4 mmHg (systolic BP; NS, diastolic BP; p < 0.05), respectively. Both groups showed a significant reduction in the coronary plaque volume of -9.4 ± 10.7% and -8.7 ± 8.6% (NS

2018 Heart and vessels

35. A Comparative Study of Electric Toothbrushes for the Efficacy Plaque Removal and the Effect on Plaque Accumulation and Gingivitis.

A Comparative Study of Electric Toothbrushes for the Efficacy Plaque Removal and the Effect on Plaque Accumulation and Gingivitis. A Comparative Study of Electric Toothbrushes for the Efficacy Plaque Removal and the Effect on Plaque Accumulation and Gingivitis. - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have (...) reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Comparative Study of Electric Toothbrushes for the Efficacy Plaque Removal and the Effect on Plaque Accumulation and Gingivitis. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before

2018 Clinical Trials

36. Effects of Statins on Coronary Atherosclerotic Plaques: The PARADIGM (Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging) Study. (PubMed)

Effects of Statins on Coronary Atherosclerotic Plaques: The PARADIGM (Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging) Study. This study sought to describe the impact of statins on individual coronary atherosclerotic plaques.Although statins reduce the risk of major adverse cardiovascular events, their long-term effects on coronary atherosclerosis remain unclear.We performed a prospective, multinational study consisting of a registry of consecutive (...) patients without history of coronary artery disease who underwent serial coronary computed tomography angiography at an interscan interval of ≥2 years. Atherosclerotic plaques were quantitatively analyzed for percent diameter stenosis (%DS), percent atheroma volume (PAV), plaque composition, and presence of high-risk plaque (HRP), defined by the presence of ≥2 features of low-attenuation plaque, positive arterial remodeling, or spotty calcifications.Among 1,255 patients (60 ± 9 years of age; 57% men

2018 JACC. Cardiovascular imaging

37. Quantitative Extent of Atherosclerotic Plaque in the Major Epicardial Coronary Arteries in Patients with Fatal Coronary Heart Disease, in Coronary Endarterectomy Specimens, in Aorta-Coronary Saphenous Venous Conduits, and Means to Prevent the Plaques: A R (PubMed)

Quantitative Extent of Atherosclerotic Plaque in the Major Epicardial Coronary Arteries in Patients with Fatal Coronary Heart Disease, in Coronary Endarterectomy Specimens, in Aorta-Coronary Saphenous Venous Conduits, and Means to Prevent the Plaques: A R This review tries to answer the following 15 questions: Is atherosclerosis a systemic or a regional disease? Is atherosclerosis in any particular region focal or diffuse? What is the quantity of atherosclerotic plaques in endarterectomy (...) specimens of the right coronary artery in patients undergoing coronary artery bypass grafting (CABG) compared to that in the right coronary artery in patients with fatal coronary artery disease? How do the units used for measuring arterial narrowing by angiography compare to the units used for measuring arterial narrowing at necropsy? What do atherosclerotic plaques consist of in coronary arteries in patients with fatal coronary disease? What is the quantity of atherosclerotic plaque in bypassed -vs

2018 American Journal of Cardiology

38. Plaque Morphology as Predictor of Late Plaque Events in Patients With Asymptomatic Type 2 Diabetes: A Long-Term Observational Study. (PubMed)

Plaque Morphology as Predictor of Late Plaque Events in Patients With Asymptomatic Type 2 Diabetes: A Long-Term Observational Study. We used coronary computed tomography angiography (CTA) to determine plaque characteristics predicting individual late plaque events precipitating acute coronary syndromes (ACS) in a cohort of asymptomatic type 2 diabetic patients.In patients with coronary artery disease, CTA plaque characteristics may predict mid-term patient events.Asymptomatic patients (...) with diabetes 55 to 74 years of age with no history of coronary artery disease (N = 630) underwent baseline 64-slice CTA and detailed plaque level analysis. All subsequent clinical events were recorded and adjudicated. In patients who developed ACS, culprit plaque was identified at invasive angiography and its precursor located on the baseline CTA. Plaque characteristics predicting an ACS-associated culprit plaque event were analyzed by time to event accounting for inpatient clustering of plaques

2018 JACC. Cardiovascular imaging

39. Impact of coronary plaque geometry on plaque vulnerability and its association with the risk of future cardiovascular events in patients with chest pain undergoing coronary computed tomographic angiography-the GEOMETRY study: Protocol for a prospective cl (PubMed)

Impact of coronary plaque geometry on plaque vulnerability and its association with the risk of future cardiovascular events in patients with chest pain undergoing coronary computed tomographic angiography-the GEOMETRY study: Protocol for a prospective cl Coronary computed tomography angiography (CCTA) has emerged as a valuable noninvasive imaging tool for assessing atheromatous plaque morphology and composition, and several CCTA features have been validated as reliable indicators of the plaque (...) -associated risk. However, the role of lesion geometry as a CCTA feature of plaque vulnerability has not been investigated so far.Here we present the study protocol of the GEOMETRY trial, a prospective, single center, cohort study in which we aim to investigate the relationship between plaque geometry (as expressed by cross-sectional and longitudinal plaque eccentricity) and the risk for major adverse cardiac events (MACE) during 2 years of follow-up, in order to validate plaque eccentricity as a new CCTA

2018 Medicine

40. Longitudinal assessment of coronary plaque volume change related to glycemic status using serial coronary computed tomography angiography: A PARADIGM (Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging) substudy. (PubMed)

Longitudinal assessment of coronary plaque volume change related to glycemic status using serial coronary computed tomography angiography: A PARADIGM (Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging) substudy. Data on the impact of glycemic status on coronary plaque progression have been limited. This study evaluated the association between glycemic status and coronary plaque volume change (PVC) using coronary computed tomography angiography (CCTA (...) ).A total of 1296 subjects (61 ± 9, 56.9% male) who underwent serial CCTA with available glycemic status were enrolled and analyzed from the Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography IMaging (PARADIGM) registry. The median inter-scan period was 3.2 (2.6-4.4) years. Quantitative assessment of coronary plaques was performed at both scans. All participants were categorized into the following groups according to glycemic status: normal, pre-diabetes (pre-DM

2018 Journal of cardiovascular computed tomography

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>